Psychiatry

Many psychiatric symptoms are self-reported, leading to potential biases and variability in data.

iNGENū CRO addresses this pain point with Objective Biomarkers

iNGENū CRO is at the forefront of developing and implementing objective biomarkers, such as advanced imaging techniques and blood-based diagnostics, to reduce reliance on subjective self-reports and improve the accuracy of psychiatric disorder assessments.

There's often a wide range of symptoms within a single diagnosis, making it challenging to assess treatment effects across a broad patient population.

iNGENū addresses this pain point with Stratified and Personalised Medicine

iNGENū CRO employs advanced patient stratification techniques to identify specific subtypes within psychiatric disorders, allowing for targeted therapeutic interventions that lead to more precise and meaningful clinical outcomes.

Psychiatric trials frequently experience strong placebo responses, making it difficult to demonstrate the true efficacy of an investigational treatment.

iNGENū addresses this pain point with Adaptive Trial Designs

To counteract placebo effects, iNGENū CRO utilises adaptive trial designs that allow real-time modifications based on interim data. These designs enhance trial efficiency while improving the ability to detect genuine treatment responses.

Psychiatric studies often face recruitment and retention difficulties due to stigma, symptom severity, or concerns about experimental treatments.

iNGENū addresses this pain point with Patient Engagement Strategies

iNGENū CRO collaborates closely with patient advocacy groups, integrates digital recruitment methods, and offers decentralised trial options to improve accessibility, enhance patient comfort, and optimise retention rates.

Balancing the risks and benefits of psychiatric trials – particularly for vulnerable populations or novel therapies – can be complex.

iNGENū addresses this pain point with Rigorous Ethical Framework & Patient-Centric Approach

iNGENū CRO ensures strict adherence to ethical guidelines, working closely with ethics committees and implementing patient-centric methodologies to protect participant wellbeing while facilitating scientific progress.